New onset diabetes manifesting as diabetic ketoacidosis in a patient with chronic myelogenous leukemia treated with imatinib. [PDF]
Salimova D +4 more
europepmc +1 more source
Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia. [PDF]
Yang Z +7 more
europepmc +1 more source
Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. [PDF]
Sharma S +8 more
europepmc +1 more source
Imatinib-Induced Bone Marrow Aplasia in Chronic Myelogenous Leukemia. [PDF]
Dogra R, Dogra V, Shelke AR.
europepmc +1 more source
Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]
Zhu F, Wang H, Qiu L.
europepmc +1 more source
Bilateral intracochlear hemorrhage: A rare onset of chronic myelogenous leukemia. [PDF]
Flahat B, Bonnard Å, Arebro J.
europepmc +1 more source
Assessment of Treatment Outcome in Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors: Insight From a Resource Limited Setting. [PDF]
Awlachew WY +4 more
europepmc +1 more source
Living with chronic myelogenous leukemia in rural communities: Exploring factors related to tyrosine kinase inhibitors adherence with a mixed methods approach. [PDF]
Sheng J +5 more
europepmc +1 more source
CDK8/19 inhibition attenuates G1 arrest induced by BCR-ABL antagonists and accelerates death of chronic myelogenous leukemia cells. [PDF]
Khamidullina AI +17 more
europepmc +1 more source

